Evidence map›Paper›PMID 26401329›Full record

ArticleCanine genetics and epidemiology2015

Prevalence and risk factors for mast cell tumours in dogs in England.

Stephanie Jw Shoop, Stephanie Marlow, David B Church, Kate English, Paul D McGreevy, Anneliese J Stell, Peter C Thomson, Dan G O'Neill, David C Brodbelt

Abstract read
In one paragraph

Article in Canine genetics and epidemiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cutaneous mast cell tumors in dogs: Association with gonadectomy.Brazilian journal of veterinary medicine · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. An increase in the urinary levels of prostaglandin DThe Journal of veterinary medical science · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Mutational Landscape ofVeterinary sciences · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stephanie Jw ShoopArthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Oxford Road, Manchester, M13 9PT England.
Stephanie MarlowVeterinary Epidemiology, Economics and Population Health, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield Herts, AL9 7TA England.
David B ChurchSmall Animal Medicine and Surgery Group, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield Herts, AL9 7TA England.
Kate EnglishPathology and Pathogen Biology, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield Herts, AL9 7TA England.
Paul D McGreevyR.M.C. Gunn Building (B19), Faculty of Veterinary Science, The University of Sydney, Sydney, NSW 2006 Australia.
Anneliese J StellSmall Animal Medicine and Surgery Group, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield Herts, AL9 7TA England.
Peter C ThomsonR.M.C. Gunn Building (B19), Faculty of Veterinary Science, The University of Sydney, Sydney, NSW 2006 Australia.
Dan G O'NeillVeterinary Epidemiology, Economics and Population Health, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield Herts, AL9 7TA England.
David C BrodbeltVeterinary Epidemiology, Economics and Population Health, The Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield Herts, AL9 7TA England.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMast cell tumour (MCT) appears to be a frequent tumour type in dogs, though there is little published in relation to its frequency in dogs in the UK. The current study aimed to investigate prevalence and risk factors for MCTs in dogs attending English primary-care veterinary practices.

methodsElectronic patient records from practices participating in the VetCompass animal surveillance project between July 2007 and June 2013 were searched for MCT diagnosis. Various search terms and standard diagnostic terms (VeNom codes) identified records containing MCT diagnoses, which were evaluated against clinical criteria for inclusion to the study. MCT prevalence for the entire dataset and specific breed types were calculated. Descriptive statistics characterised MCT cases and multivariable logistic regression methods evaluated risk factors for association with MCT (P < 0.05).

resultsWithin a population of 168,636 dogs, 453 had MCT, yielding a prevalence of 0.27% (95% confidence interval (CI) 0.24% - 0.29%). The highest breed type specific prevalences were for the Boxer at 1.95% (95% CI 1.40% - 2.51%), Golden Retriever at 1.39% (0.98% - 1.81%) and Weimaraner at 0.85% (95% CI 0.17% to 1.53%). Age, insurance status, neuter status, weight and breed type were associated with MCT diagnosis. Of dogs of specific breed type, the Boxer, Pug and Staffordshire Bull Terrier showed greater odds of MCT diagnosis compared with crossbred dogs. Conversely, the German Shepherd Dog, Border Collie, West Highland White Terrier, Springer Spaniel and Cocker Spaniel had reduced odds of MCT diagnosis compared with crossbred dogs. No association was found between MCT diagnosis and sex. CLINICAL SIGNIFICANCE: This study highlights a clinically significant prevalence of MCT and identifies specific breed types with predisposition to MCT, potentially aiding veterinarian awareness and facilitating diagnosis.

Indexed as

CanineEpidemiologyMast cellMastocytomaOncologyPrevalencePrimary-care practice

Identifiers

PMID26401329
PMCPMC4579370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.